Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics Den europeiske union - norsk - EMA (European Medicines Agency)

prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics

novartis vaccines and diagnostics s.r.l. - influensavirusoverflateantigener (hemagglutinin og neuraminidase) av stamme a / viet nam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - vaksiner - aktiv immunisering mot h5n1 subtype av influensa a-virus. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.

Vancomycin Fresenius Kabi 1 g Norge - norsk - Statens legemiddelverk

vancomycin fresenius kabi 1 g

fresenius kabi norge as - halden - vankomycinhydroklorid - pulver til konsentrat til infusjonsvæske, oppløsning - 1 g

Vancomycin Fresenius Kabi 500 mg Norge - norsk - Statens legemiddelverk

vancomycin fresenius kabi 500 mg

fresenius kabi norge as - halden - vankomycinhydroklorid - pulver til konsentrat til infusjonsvæske, oppløsning - 500 mg

Vancomycin Xellia 500 mg Norge - norsk - Statens legemiddelverk

vancomycin xellia 500 mg

xellia pharmaceuticals a. p. s - vankomycinhydroklorid - pulver til infusjonsvæske, oppløsning - 500 mg

Vancomycin Xellia 125 mg Norge - norsk - Statens legemiddelverk

vancomycin xellia 125 mg

xellia pharmaceuticals a. p. s - vankomycinhydroklorid - kapsel, hard - 125 mg

Vancomycin MIP 1 g Norge - norsk - Statens legemiddelverk

vancomycin mip 1 g

mip pharma gmbh - vankomycinhydroklorid - pulver til infusjonsvæske, oppløsning - 1 g

Vancomycin Strides 125 mg Norge - norsk - Statens legemiddelverk

vancomycin strides 125 mg

strides pharma (cyprus) limited - vankomycinhydroklorid - kapsel, hard - 125 mg

Vancomycin MIP 500 mg Norge - norsk - Statens legemiddelverk

vancomycin mip 500 mg

mip pharma gmbh - vankomycinhydroklorid - pulver til infusjonsvæske, oppløsning - 500 mg

Zoonotic Influenza Vaccine Seqirus Den europeiske union - norsk - EMA (European Medicines Agency)

zoonotic influenza vaccine seqirus

seqirus s.r.l.  - zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted), influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: a/turkey/turkey/1/05 (h5n1)-like strain (nibrg-23) - influenza a virus, h5n1 subtype - vaksiner - active immunisation against h5 subtype of influenza a virus.

COVID-19 Vaccine (inactivated, adjuvanted) Valneva Den europeiske union - norsk - EMA (European Medicines Agency)

covid-19 vaccine (inactivated, adjuvanted) valneva

valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - vaksiner - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age.  the use of this vaccine should be in accordance with official recommendations.